...
首页> 外文期刊>International Journal of Pharmaceutics >Dual 0.02% chlorhexidine digluconate-0.1% disodium EDTA loaded thermosensitive ocular gel for Acanthamoeba keratitis treatment
【24h】

Dual 0.02% chlorhexidine digluconate-0.1% disodium EDTA loaded thermosensitive ocular gel for Acanthamoeba keratitis treatment

机译:双0.02%氯己定Digluconate-0.1%二钠加载热敏眼凝胶,用于Acanthamoeba角膜炎治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Poor bioavailability and low residence time limit the efficiency of conventional biguanide-based eye drops against Acanthamoeba keratitis. The aim of this work was to formulate an original anti-amoebic thermoreversible ocular gel combining biguanide and metalloproteases inhibitor - chelating agent. Chlorhexidine digluconate (CHX)-ethylenediaminetetraacetic acid disodium salt (Na(2)EDTA) were compounded in poloxamer 407 saline solution. 0.02% CHX - 0.1% Na(2)EDTA loaded thermosensitive ocular gel exhibited appropriate pH (5.73 +/- 0.06), iso-osmolality (314 +/- 5 mOsm/kg), viscosity (ranged between 15 and 25 mPa.s) and thermal gelation (26.5 degrees C and 33 degrees C) properties. Bioadhesion of gel was successfully tested onto isolated bovine eyes as well as the assessment of CHX penetration into the cornea. Intracorneal CHX concentration was found greater than trophozoite minimum amoebicidal concentration and minimal cysticidal concentration after 15-min and 2-h ocular exposure, respectively, while any CHX permeation through the cornea was detected ( 51 ng/cm(2)/h). Improvement of CHX ocular bioavailability was attributed to probable solubilization of tear film lipid layer by poloxamer. In vitro efficiency of CHX-Na(2)EDTA ocular gel was confirmed from the drastic reduction of trophozoite and cyst survival (to 25% and 2%, respectively), confirming the potential of the multicomponent pharmaceutical material strategy for the treatment of Acanthamoeba keratitis.
机译:生物利用度低,低置时间限制了常规的双胍型眼滴对抗acanthamoeba角膜炎的效率。这项工作的目的是配制原始的抗氨基热可逆眼凝胶,组合双胍和金属蛋白酶抑制剂 - 螯合剂。将氯己定Digluconate(CHX) - 乙二胺四乙酸二钠盐(Na(2)EDTA)在泊洛沙姆407盐水溶液中配混。 0.02%CHX - 0.1%NA(2)EDTA负载热敏眼凝胶表现出适当的pH(5.73 +/- 0.06),异溶性(314 +/- 5 mOSM / kg),粘度(范围在15到25 MPa.s之间)和热凝胶化(26.5℃和33℃)性质。凝胶的生物粘合成功地测试了分离的牛眼,以及对角膜中的CHX渗透的评估。在15分钟和2-H眼暴露后,发现肠道CHX浓度大于滋养体最小氨基磷酸盐浓度和最小囊性浓度,而检测到通过角膜的任何CHX渗透(& 51 ng / cm(2)/ h) 。 CHX眼生物利用度的提高归因于泊洛沙姆的泪膜脂层的可能溶解。 CHX-Na(2)EDTA眼凝胶的体外效率从滋养色素和囊肿存活的急剧降低确认(分别为25%和2%),确认了用于治疗Acanthamoeba角膜炎的多组分药物材料策略的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号